Delhi-NCR based Rio Health has secured $4.5 million in a pre-Series A round to expand its dark-store network and AI-based inventory system. The pharmacy delivery startup processes 30,000 orders monthly and aims to capture a larger share of the quick-commerce market while balancing strict medical licensing requirements against major competitors.
Rio Health, a Delhi-NCR startup focused on quick pharmacy deliveries, has raised $4.5 million in a pre-Series A funding round. Version One Ventures led the investment, with follow-on support from existing investors Xeed Ventures, Good Capital, and Amplify. This funding brings the company’s total cumulative capital to approximately Rs 62.24 crore.
The startup intends to use the money to increase the number of its dark stores, which are small local warehouses that stock inventory closer to customers. By improving its AI-powered demand forecasting, the company wants to ensure essential medicines are available and delivered in under 30 minutes. Founders Ankur Agrawal and Amit Ahuja believe this specialized focus on speed and reliability helps them compete against general quick-commerce platforms that are also moving into pharmacy delivery.
Currently, Rio Health processes over 30,000 orders each month, with an average transaction value between Rs 600 and Rs 700. The company targets an annual run rate of more than Rs 150 crore in the next year. To operate, the business uses a combination of automated prescription scanning and manual verification by licensed pharmacists. This is a critical step because, unlike grocery delivery, pharmacy operations require strict compliance with healthcare regulations and precise supply chain controls.
The pharmacy delivery sector is significantly more complex than standard quick-commerce due to legal requirements regarding drug sales and the necessity for valid prescription authentication. While major players like Blinkit, Zepto, and Swiggy Instamart are expanding their offerings to include medicines, they face operational hurdles that specialized pharmacy startups also navigate. For Rio Health, the primary challenge remains maintaining profit margins while absorbing the high costs associated with rapid delivery logistics. The company also faces intense competition from these well-funded quick-commerce giants, which have significant resources for marketing and expansion. Any failure in prescription verification or supply chain execution could pose significant legal and regulatory risks. Investors will track whether the company can reach its revenue targets while navigating these operational complexities and maintaining strict adherence to medical safety standards.